Clinical Trial Detail

NCT ID NCT03456700
Title Auranofin and Sirolimus in Treating Participants With Ovarian Cancer
Recruitment Suspended
Gender female
Phase Phase II
Variant Requirements no
Sponsors Mayo Clinic
Indications

ovarian cancer

Therapies

Auranofin + Sirolimus

Age Groups: senior adult

No variant requirements are available.